Authors : Sharda S. Kulkarni; Rutuja Dhormare; Sarang D. Kulkarni

Volume/Issue : Volume 10 - 2025, Issue 5 - May

Google Scholar : https://tinyurl.com/4m3e2zk9

DOI : https://doi.org/10.38124/ijisrt/25may1018

Note : A published paper may take 4-5 working days from the publication date to appear in PlumX Metrics, Semantic Scholar, and ResearchGate.

Abstract : Chronic Obstructive Pulmonary Disease (COPD) is one of the mostlong term pulmonary infection associated with difficulties in normal respiration process due to blocked airflow via bronchioles. Salbutamol is a commonly used bronchodilator that helps open the airways, but traditional oral tablets may work slowly because they take time to dissolve and absorb. This delay can be a problem for elderly patients or those who have trouble swallowing. This research aims to develop and test effervescent tablets containing Salbutamol to provide faster relief and easier administration for patients with COPD. Effervescent tablets dissolve quickly in water, forming a fizzy solution that is easy to swallow and allows for faster drug absorption. In this study, Salbutamol was combined with ingredients like sodium bicarbonate, citric acid, and tartaric acid using the wet granulation method. These ingredients were chosen for their ability to produce a fast- dissolving, stable, and effective tablet. The properties of Salbutamol, such as solubility and stability, were studied to ensure accurate dosage and proper function. The prepared tablets were tested for weight variation, thickness, hardness, friability, effervescence time, and disintegration time to confirm quality and performance. Some tablets were also designed to float in the stomach to improve absorption over time. The results showed that the effervescent tablets delivered Salbutamol quickly and effectively, offering a useful alternative for treating COPD symptoms. This type of tablet can improve patient comfort, compliance, and treatment outcomes, especially for those who have difficulty swallowing regular tablets.

Keywords : COPD, Salbutamol, Effervescent Tablets.

References :

1. Deepak Sharma, R. Zelko , A. S. Zidan, Formulation Development and Evaluation of Fast DisintegratingTablets of Salbutamol Sulphate for Respiratory Disorders, Hindawi Publishing Corporation ISRN Pharmaceutics Volume 2013, Article ID 674507, 8 pages http://dx.doi.org/10.1 155/2013/674507
2. Patel SG, Siddiqah M, Formulation and evaluation of effervescent tablets: a review, Journal of Drug Delivery and Therapeutics. 2018; 8(6): 296-303 DOI: http://dx.doi.org/10.22270/jddt.v8i6.2021.
3. Himanshu Dutt , Girish Kumar Dwivedi , Satyendra Kumar, Formulation, Optimization and Evaluation of Oral Buoyant Effervescent Tablets of Salbutamol Sulphate, Human Journals Research Article July 2023 Vol.:27, Issue:4
4. N.M. Sallam , R.Abdel-b. Sanad , R.Kharshoum , M. Zineldin, Development of Salbutamol Sulphate fast disintegrating sublingual tablets with enhanced bioavailability and improved clinical efficacy for potential treatment of copd Journal of drug delivery science and technology volume 41, October 2017, Pages 78-89
5. Taj T. Razzouk*, Jamileh A. Hasian, Effect of Different Excipients on Retarding Salbutamol Sulphate Release from Floating Effervescent Tablets, Int. J. Pharm. Sci. Rev. Res., 23(2), Nov – Dec 2013; nᵒ 49, 307-313.